Annual Cash & Cash Equivalents
$277.92 M
+$4.06 M+1.48%
December 31, 2023
Summary
- As of February 8, 2025, INBX annual cash & cash equivalents is $277.92 million, with the most recent change of +$4.06 million (+1.48%) on December 31, 2023.
- During the last 3 years, INBX annual cash & cash equivalents has risen by +$149.26 million (+116.01%).
- INBX annual cash & cash equivalents is now at all-time high.
Performance
INBX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$196.33 M
-$30.53 M-13.46%
September 30, 2024
Summary
- As of February 8, 2025, INBX quarterly cash and cash equivalents is $196.33 million, with the most recent change of -$30.53 million (-13.46%) on September 30, 2024.
- Over the past year, INBX quarterly cash and cash equivalents has dropped by -$30.53 million (-13.46%).
- INBX quarterly cash and cash equivalents is now -41.80% below its all-time high of $337.33 million, reached on September 30, 2023.
Performance
INBX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
INBX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.5% | -13.5% |
| 3 y3 years | +116.0% | -16.2% |
| 5 y5 years | +10000.0% | -16.2% |
INBX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +111.7% | -41.8% | +49.5% |
| 5 y | 5-year | at high | +2308.3% | -41.8% | +3386.0% |
| alltime | all time | at high | >+9999.0% | -41.8% | +3386.0% |
Inhibrx Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $196.33 M(-13.5%) |
| Jun 2024 | - | $226.86 M(-10.1%) |
| Mar 2024 | - | $252.48 M(-9.2%) |
| Dec 2023 | $277.92 M(+1.5%) | $277.92 M(-17.6%) |
| Sep 2023 | - | $337.33 M(+75.2%) |
| Jun 2023 | - | $192.49 M(-17.8%) |
| Mar 2023 | - | $234.25 M(-14.5%) |
| Dec 2022 | $273.87 M(+108.6%) | $273.87 M(+87.5%) |
| Sep 2022 | - | $146.07 M(-17.2%) |
| Jun 2022 | - | $176.38 M(+22.9%) |
| Mar 2022 | - | $143.47 M(+9.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $131.30 M(+2.0%) | $131.30 M(+16.5%) |
| Sep 2021 | - | $112.70 M(-10.4%) |
| Jun 2021 | - | $125.73 M(+16.4%) |
| Mar 2021 | - | $107.99 M(-16.1%) |
| Dec 2020 | $128.66 M(+1014.9%) | $128.66 M(+0.8%) |
| Sep 2020 | - | $127.67 M(+2166.9%) |
| Jun 2020 | - | $5.63 M(-51.2%) |
| Dec 2019 | $11.54 M(+448.7%) | $11.54 M(-58.2%) |
| Jun 2019 | - | $27.63 M(+342.4%) |
| Mar 2019 | - | $6.24 M |
| Dec 2018 | $2.10 M(-84.4%) | - |
| Dec 2017 | $13.47 M | - |
FAQ
- What is Inhibrx Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Inhibrx Biosciences?
- What is Inhibrx Biosciences annual cash & cash equivalents year-on-year change?
- What is Inhibrx Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Inhibrx Biosciences?
- What is Inhibrx Biosciences quarterly cash and cash equivalents year-on-year change?
What is Inhibrx Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of INBX is $277.92 M
What is the all time high annual cash & cash equivalents for Inhibrx Biosciences?
Inhibrx Biosciences all-time high annual cash & cash equivalents is $277.92 M
What is Inhibrx Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, INBX annual cash & cash equivalents has changed by +$4.06 M (+1.48%)
What is Inhibrx Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of INBX is $196.33 M
What is the all time high quarterly cash and cash equivalents for Inhibrx Biosciences?
Inhibrx Biosciences all-time high quarterly cash and cash equivalents is $337.33 M
What is Inhibrx Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, INBX quarterly cash and cash equivalents has changed by -$30.53 M (-13.46%)